Clinical trial
Thalidomide Therapy for Very Early Onset Inflammatory Bowel Disease
NCT06382519 is registered in ClinicalTrials.gov with Children's Hospital of Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thalidomide Therapy for Very Early Onset Inflammatory Bowel Disease
- Lead sponsor
- Children's Hospital of Fudan University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 15, 2024
- Completion date
- December 31, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.